Your browser doesn't support javascript.
loading
Suppression of Ca2+ signaling enhances melanoma progression.
Gross, Scott; Hooper, Robert; Tomar, Dhanendra; Armstead, Alexander P; Shanas, No'ad; Mallu, Pranava; Joshi, Hinal; Ray, Suravi; Chong, Parkson Lee-Gau; Astsaturov, Igor; Farma, Jeffrey M; Cai, Kathy Q; Chitrala, Kumaraswamy Naidu; Elrod, John W; Zaidi, M Raza; Soboloff, Jonathan.
Afiliação
  • Gross S; Fels Cancer Institute for Personalized Medicine, The Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.
  • Hooper R; Fels Cancer Institute for Personalized Medicine, The Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.
  • Tomar D; The Center for Translational Medicine, The Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.
  • Armstead AP; Fels Cancer Institute for Personalized Medicine, The Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.
  • Shanas N; Fels Cancer Institute for Personalized Medicine, The Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.
  • Mallu P; Fels Cancer Institute for Personalized Medicine, The Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.
  • Joshi H; Department of Cancer and Cellular Biology, The Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.
  • Ray S; Fels Cancer Institute for Personalized Medicine, The Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.
  • Chong PL; Department of Cancer and Cellular Biology, The Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.
  • Astsaturov I; Fels Cancer Institute for Personalized Medicine, The Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.
  • Farma JM; Department of Cancer and Cellular Biology, The Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.
  • Cai KQ; Department of Cancer and Cellular Biology, The Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.
  • Chitrala KN; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Elrod JW; Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Zaidi MR; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Soboloff J; Fels Cancer Institute for Personalized Medicine, The Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.
EMBO J ; 41(19): e110046, 2022 10 04.
Article em En | MEDLINE | ID: mdl-36039850
ABSTRACT
The role of store-operated Ca2+ entry (SOCE) in melanoma metastasis is highly controversial. To address this, we here examined UV-dependent metastasis, revealing a critical role for SOCE suppression in melanoma progression. UV-induced cholesterol biosynthesis was critical for UV-induced SOCE suppression and subsequent metastasis, although SOCE suppression alone was both necessary and sufficient for metastasis to occur. Further, SOCE suppression was responsible for UV-dependent differences in gene expression associated with both increased invasion and reduced glucose metabolism. Functional analyses further established that increased glucose uptake leads to a metabolic shift towards biosynthetic pathways critical for melanoma metastasis. Finally, examination of fresh surgically isolated human melanoma explants revealed cholesterol biosynthesis-dependent reduced SOCE. Invasiveness could be reversed with either cholesterol biosynthesis inhibitors or pharmacological SOCE potentiation. Collectively, we provide evidence that, contrary to current thinking, Ca2+ signals can block invasive behavior, and suppression of these signals promotes invasion and metastasis.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sinalização do Cálcio / Melanoma Limite: Humans Idioma: En Revista: EMBO J Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sinalização do Cálcio / Melanoma Limite: Humans Idioma: En Revista: EMBO J Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos